Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Rempex Pharmaceuticals patents

Patents where

Current Assignee

Name

Rempex Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9687497 Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof	Patent 9687497 was granted and assigned to Rempex Pharmaceuticals on June, 2017 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9687497	June 27, 2017
‌ US Patent 9642869 Boronic acid derivatives and therapeutic uses thereof	Patent 9642869 was granted and assigned to Rempex Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9642869	May 9, 2017
‌ US Patent 9296763 Cyclic boronic acid ester derivatives and therapeutic uses thereof	Patent 9296763 was granted and assigned to Rempex Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9296763	March 29, 2016
‌ US Patent 10172874 Pharmaceutical compositions comprising cyclic boronic acid ester derivatives	Patent 10172874 was granted and assigned to Rempex Pharmaceuticals on January, 2019 by the United States Patent and Trademark Office.		Rempex Pharmaceuticals	United States Patent and Trademark Office	10172874	January 8, 2019
‌ US Patent 10004758 Cyclic boronic acid ester derivatives and methods of making the same	Patent 10004758 was granted and assigned to Rempex Pharmaceuticals on June, 2018 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	10004758	June 26, 2018
‌ US Patent 9278105 Tetracycline compositions	Patent 9278105 was granted and assigned to Rempex Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9278105	March 8, 2016
‌ US Patent 9241947 Boronic acid derivatives and therapeutic uses thereof	Patent 9241947 was granted and assigned to Rempex Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9241947	January 26, 2016
‌ US Patent 9012491 Heterocyclic boronic acid ester derivatives and therapeutic uses thereof	Patent 9012491 was granted and assigned to Rempex Pharmaceuticals on April, 2015 by the United States Patent and Trademark Office.		Rempex Pharmaceuticals	United States Patent and Trademark Office	9012491	April 21, 2015
‌ US Patent 9132140 Boronic acid derivatives and therapeutic uses thereof	Patent 9132140 was granted and assigned to Rempex Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9132140	September 15, 2015
‌ US Patent 9084802 Tetracycline compositions	Patent 9084802 was granted and assigned to Rempex Pharmaceuticals on July, 2015 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9084802	July 21, 2015
‌ US Patent 9156858 Boronic acid derivatives and therapeutic uses thereof	Patent 9156858 was granted and assigned to Rempex Pharmaceuticals on October, 2015 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9156858	October 13, 2015
‌ US Patent 9101638 Boronic acid derivatives and therapeutic uses thereof	Patent 9101638 was granted and assigned to Rempex Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9101638	August 11, 2015
‌ US Patent 8680136 Cyclic boronic acid ester derivatives and therapeutic uses thereof	Patent 8680136 was granted and assigned to Rempex Pharmaceuticals on March, 2014 by the United States Patent and Trademark Office.		Rempex Pharmaceuticals	United States Patent and Trademark Office	8680136	March 25, 2014
‌ US Patent 9694025 Cyclic boronic acid ester derivatives and therapeutic uses thereof	Patent 9694025 was granted and assigned to Rempex Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9694025	July 4, 2017
‌ US Patent 8178490 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof	Patent 8178490 was granted and assigned to Rempex Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.		Rempex Pharmaceuticals	United States Patent and Trademark Office	8178490	May 15, 2012
‌ US Patent 9963467 Boronic acid derivatives and therapeutic uses thereof	Patent 9963467 was granted and assigned to Rempex Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9963467	May 8, 2018
‌ US Patent 8933018 Boron containing polybasic bacterial efflux pump inhibitors and therapeutic uses thereof	Patent 8933018 was granted and assigned to Rempex Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.		Rempex Pharmaceuticals	United States Patent and Trademark Office	8933018	January 13, 2015
‌ US Patent 7994225 Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections	Patent 7994225 was granted and assigned to Rempex Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office.		Rempex Pharmaceuticals	United States Patent and Trademark Office	7994225	August 9, 2011
‌ US Patent 9744179 Tetracycline compositions	Patent 9744179 was granted and assigned to Rempex Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.	Rempex Pharmaceuticals	Rempex Pharmaceuticals	United States Patent and Trademark Office	9744179	August 29, 2017
‌ US Patent 8906868 Aminoglycoside derivatives	Patent 8906868 was granted and assigned to Rempex Pharmaceuticals on December, 2014 by the United States Patent and Trademark Office.		Rempex Pharmaceuticals	United States Patent and Trademark Office	8906868	December 9, 2014
‌ US Patent 8268865 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof	Patent 8268865 was granted and assigned to Rempex Pharmaceuticals on September, 2012 by the United States Patent and Trademark Office.		Rempex Pharmaceuticals	United States Patent and Trademark Office	8268865	September 18, 2012

21 results

0 selected

21 results

0 selected